Fast Market Research

NAL Pharmaceuticals Ltd. - Product Pipeline Analysis, 2014 Update - New Study Released

Recently published research from GlobalData, "NAL Pharmaceuticals Ltd. - Product Pipeline Analysis, 2014 Update", is now available at Fast Market Research


Boston, MA -- (SBWIRE) -- 09/23/2014 -- NAL Pharmaceuticals Ltd. (NAL Pharma) is a pharmaceutical company. The company develops specialty drug products. It applies its drug delivery system technologies to develop novel dosage forms and delivery systems. NAL Pharma's technologies include Bio-D3 Extended-Release Transdermal Patch DDS, Bio-CR Extended-Release Nano-Particle DDS, Bio-FX Fast-Onset Oral-Cavity ODF, and Bio-MM Extended-Release Macromolecular DDS. The company's products serve therapeutic areas, such as central nervous system, oncology, arthritic and acute pain, smoking cessation, cardiovascular and allergy, and respiratory. It has presence in Japan, China, Hong Kong, Taiwan, and the US. NAL Pharma is headquartered in Causeway Bay, Hong Kong.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

View Full Report Details and Table of Contents

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company NAL Pharmaceuticals Ltd.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscap

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 800-844-8156

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Eutropics Pharmaceuticals, Inc. - Product Pipeline Analysis, 2014 Update
- Novartis AG (NOVN) - Product Pipeline Analysis, 2014 Update
- OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2014 Update
- Terumo Corporation (4543) - Product Pipeline Analysis, 2014 Update
- Radient Pharmaceuticals Corporation (RXPC) - Product Pipeline Analysis, 2013 Update
- Actavis plc (ACT) - Product Pipeline Analysis, 2014 Update
- MDxHealth SA (MDXH) - Product Pipeline Analysis, 2014 Update
- Cancer Pain - Pipeline Review, H1 2014
- Hyperlipidemia - Pipeline Review, H1 2014
- Smoking Cessation - Pipeline Review, H1 2014